Details of the Drug Reposition

General Information of This Drug (ID: DMLDJ31)

Drug Name
GSK3923868   DMLDJ31
Drug Type
Small molecule

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
2 Phase 1 Indication(s)
Indication Name Indication ID ICD-11 Status REF
COPD DIS8XV9L 1D6Y Phase 1 [1]
Chronic obstructive pulmonary disease DISQCIRF CA22 Phase 1 [1]
------------------------------------------------------------------------------------

References

1 ClinicalTrials.gov (NCT05677347) A Randomized, Double-blind, Placebo Controlled, Single and Repeat Dose Study to Assess the Safety, Tolerability, and Pharmacokinetics of Inhaled GSK3923868 in Participants With Chronic Obstructive Pulmonary Disease (COPD). U.S.National Institutes of Health.